Purpose: The purpose of this study was to assess ordering of human papillomavirus (HPV)
testing for normal cervical cytology among low-risk women aged 30 to 65 years. Methods …

Objective To evaluate the adoption of HPV testing and recommended extended cervical
cancer screening intervals in clinical practice, we described yearly uptake of Pap/HPV …

OBJECTIVE: We assessed clinician knowledge and practices since the marketing of tests for
sexually transmitted human papillomavirus (HPV) and the release of HPV testing guidelines …

If the cervical cytology report you receive for a woman in her mid-20s is negative, how soon
would you plan to repeat testing? Recommendations from the United States Preventive …

In 2009, the Cytopathology Education and Technology Consortium issued a statement on
human papillomavirus (HPV) DNA test utilization that was published in multiple journals. 1 …

Background: Millions of women in the United States receive cervical screening in sexually
transmitted disease (STD), family planning, and primary care clinical settings. Objective: To …

Objective. The purpose of this study was to demonstrate a methodology for auditing the
impact of HCII testing on the direct cost of cervical cancer cytological screening, where the …

OBJECTIVE: To assess self-reported human papillomavirus (HPV) DNA testing practices by
health care providers and clinics, including nonrecommended practices such as low-risk …

Objective The primary cervical cancer screening strategy for women over age 30 is high-risk
human papillomavirus (HPV) testing combined with Papanicolaou (Pap) testing (cotesting) …

Abstract Objective: Human papillomavirus (HPV) DNA testing combined with cytology (co-
testing) has been recommended as a primary cervical cancer screening strategy and will be …